153 related articles for article (PubMed ID: 6604090)
41. Studies on natural killer (NK) cells. II. Serologic evidence for heterogeneity of murine NK cells.
Burton RC; Bartlett SP; Kumar V; Winn HJ
J Immunol; 1981 Nov; 127(5):1864-8. PubMed ID: 6975301
[TBL] [Abstract][Full Text] [Related]
42. Effect of altered membrane structure on NK cell-mediated cytotoxicity. III. Decreased susceptibility to natural killer cytotoxic factor (NKCF) and suppression of NKCF release by membrane rigidification.
Roozemond RC; Mevissen M; Urli DC; Bonavida B
J Immunol; 1987 Sep; 139(5):1739-46. PubMed ID: 3624869
[TBL] [Abstract][Full Text] [Related]
43. Mechanisms of resistance to natural killer cell-mediated cytotoxicity in acute lymphoblastic leukemia.
Romanski A; Bug G; Becker S; Kampfmann M; Seifried E; Hoelzer D; Ottmann OG; Tonn T
Exp Hematol; 2005 Mar; 33(3):344-52. PubMed ID: 15730858
[TBL] [Abstract][Full Text] [Related]
44. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
Colotta F; Peri G; Villa A; Mantovani A
J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
[TBL] [Abstract][Full Text] [Related]
45. Re-targeting of cytotoxic T lymphocytes and/or natural killer cells to CEA-expressing tumor cells with anti-CEA antibody activity.
Kuroki M; Hachimine K; Huang J; Shibaguchi H; Kinugasa T; Maekawa S; Kuroki M
Anticancer Res; 2005; 25(6A):3725-32. PubMed ID: 16302732
[TBL] [Abstract][Full Text] [Related]
46. H-2Dp transgene alters natural killer cell specificity at the target and effector cell levels. Comparison with an H-2Dd transgene.
Sentman CL; Olsson-Alheim MY; Lendahl U; Kärre K
J Immunol; 1996 Apr; 156(7):2423-9. PubMed ID: 8786300
[TBL] [Abstract][Full Text] [Related]
47. E1A oncogene expression in target cells induces cytolytic susceptibility at a post-recognition stage in the interaction with killer lymphocytes.
Cook JL; Potter TA; Bellgrau D; Routes BA
Oncogene; 1996 Aug; 13(4):833-42. PubMed ID: 8761305
[TBL] [Abstract][Full Text] [Related]
48. Trophoblast cell line resistance to NK lysis mainly involves an HLA class I-independent mechanism.
Avril T; Jarousseau AC; Watier H; Boucraut J; Le Bouteiller P; Bardos P; Thibault G
J Immunol; 1999 May; 162(10):5902-9. PubMed ID: 10229826
[TBL] [Abstract][Full Text] [Related]
49. Mouse natural killer subsets defined by their target specificity and their ability to be separately rendered unresponsive in vivo.
Kung SK; Miller RG
J Immunol; 1997 Mar; 158(6):2616-26. PubMed ID: 9058794
[TBL] [Abstract][Full Text] [Related]
50. Interferon-induced resistance of fibroblasts to cytolysis mediated by natural killer cells: specificity and mechanism.
Trinchieri G; Granato D; Perussia B
J Immunol; 1981 Jan; 126(1):335-40. PubMed ID: 7451975
[TBL] [Abstract][Full Text] [Related]
51. Differential natural killer cell reactivity against T cell lymphomas by cells from normal or stimulated mice.
Tai A; Burton RC; Warner NL
J Immunol; 1980 Apr; 124(4):1705-11. PubMed ID: 6965957
[TBL] [Abstract][Full Text] [Related]
52. Solid tumor-derived target cell susceptibility to macrophages and natural killer/natural cytotoxic cells in the rat.
Zöller M; Matzku S
Immunobiology; 1983 May; 164(5):349-60. PubMed ID: 6603412
[TBL] [Abstract][Full Text] [Related]
53. Evidence for indirect involvement of the H-2Kb gene in the regulation of natural killer sensitivity of BL6 melanoma cells.
Kim M; Herberman R; Gorelik E
Nat Immun; 1994; 13(1):1-14. PubMed ID: 8111189
[TBL] [Abstract][Full Text] [Related]
54. NK and CTL recognition of a single chain H-2Dd molecule: distinct sites of H-2Dd interact with NK and TCR.
Chung DH; Dorfman J; Plaksin D; Natarajan K; Belyakov IM; Hunziker R; Berzofsky JA; Yokoyama WM; Mage MG; Margulies DH
J Immunol; 1999 Oct; 163(7):3699-708. PubMed ID: 10490965
[TBL] [Abstract][Full Text] [Related]
55. NK cells from human MHC class I (HLA-B) transgenic mice do not mediate hybrid resistance killing against parental nontransgenic cells.
Kung SK; Su RC; Graham JJ; Chamberlain JW; Miller RG
J Immunol; 1998 Jan; 160(2):674-80. PubMed ID: 9551902
[TBL] [Abstract][Full Text] [Related]
56. Adenovirus-interleukin-12-mediated tumor regression in a murine hepatocellular carcinoma model is not dependent on CD1-restricted natural killer T cells.
Andrews KJ; Ribas A; Butterfield LH; Vollmer CM; Eilber FC; Dissette VB; Nelson SD; Shintaku P; Mekhoubad S; Nakayama T; Taniguchi M; Glaspy JA; McBride WH; Economou JS
Cancer Res; 2000 Nov; 60(22):6457-64. PubMed ID: 11103813
[TBL] [Abstract][Full Text] [Related]
57. Increased natural killer cell activity in experimental American trypanosomiasis.
Hatcher FM; Kuhn RE; Cerrone MC; Burton RC
J Immunol; 1981 Sep; 127(3):1126-30. PubMed ID: 6790614
[TBL] [Abstract][Full Text] [Related]
58. Peyer's patch lymphocytes express natural cytotoxicity but not natural killer activity.
Tagliabue A; Villa L; Scapigliati G; Boraschi D
Nat Immun Cell Growth Regul; 1983-1984; 3(2):95-101. PubMed ID: 6436693
[TBL] [Abstract][Full Text] [Related]
59. A novel type of human T cell clone with highly potent natural killer-like cytotoxicity divorced from large granular lymphocyte morphology.
Schneider EM; Pawelec GP; Liangru S; Wernet P
J Immunol; 1984 Jul; 133(1):173-9. PubMed ID: 6609974
[TBL] [Abstract][Full Text] [Related]
60. NK 1+ CD4- CD8- alphabeta T cells in the peritoneal cavity: specific T cell receptor-mediated cytotoxicity and selective IFN-gamma production against B cell leukemia and myeloma cells.
Sugie T; Kubota H; Sato M; Nakamura E; Imamura M; Minato N
J Immunol; 1996 Nov; 157(9):3925-35. PubMed ID: 8892624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
